309 related articles for article (PubMed ID: 29684121)
1. Incidence and prevalence of diabetes and cost of illness analysis of polycystic ovary syndrome: a Bayesian modelling study.
Ding T; Hardiman PJ; Petersen I; Baio G
Hum Reprod; 2018 Jul; 33(7):1299-1306. PubMed ID: 29684121
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.
Cooney LG; Lee I; Sammel MD; Dokras A
Hum Reprod; 2017 May; 32(5):1075-1091. PubMed ID: 28333286
[TBL] [Abstract][Full Text] [Related]
3. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span.
Azziz R; Marin C; Hoq L; Badamgarav E; Song P
J Clin Endocrinol Metab; 2005 Aug; 90(8):4650-8. PubMed ID: 15944216
[TBL] [Abstract][Full Text] [Related]
4. Direct economic burden of mental health disorders associated with polycystic ovary syndrome: Systematic review and meta-analysis.
Yadav S; Delau O; Bonner AJ; Markovic D; Patterson W; Ottey S; Buyalos RP; Azziz R
Elife; 2023 Aug; 12():. PubMed ID: 37534878
[TBL] [Abstract][Full Text] [Related]
5. The effects of smoking on pregnancy risks in women with polycystic ovary syndrome: a population-based study.
Feferkorn I; Badeghiesh A; Mills G; Baghlaf H; Dahan M
Hum Reprod; 2021 Aug; 36(9):2549-2557. PubMed ID: 34164665
[TBL] [Abstract][Full Text] [Related]
6. Excess mortality in mothers of patients with polycystic ovary syndrome.
Louwers YV; Roest-Schalken ME; Kleefstra N; Roeters van Lennep J; van den Berg M; Fauser BC; Bilo HJ; Sijbrands EJ; Laven JS
Hum Reprod; 2014 Aug; 29(8):1780-6. PubMed ID: 24876175
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of Type 2 diabetes is not increased in normal-weight women with PCOS.
Pelanis R; Mellembakken JR; Sundström-Poromaa I; Ravn P; Morin-Papunen L; Tapanainen JS; Piltonen T; Puurunen J; Hirschberg AL; Fedorcsak P; Andersen M; Glintborg D
Hum Reprod; 2017 Nov; 32(11):2279-2286. PubMed ID: 29040530
[TBL] [Abstract][Full Text] [Related]
8. Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017.
Liu J; Wu Q; Hao Y; Jiao M; Wang X; Jiang S; Han L
Hum Reprod; 2021 Mar; 36(4):1108-1119. PubMed ID: 33501984
[TBL] [Abstract][Full Text] [Related]
9. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.
Bozdag G; Mumusoglu S; Zengin D; Karabulut E; Yildiz BO
Hum Reprod; 2016 Dec; 31(12):2841-2855. PubMed ID: 27664216
[TBL] [Abstract][Full Text] [Related]
10. Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies.
Mills G; Badeghiesh A; Suarthana E; Baghlaf H; Dahan MH
Hum Reprod; 2020 Jul; 35(7):1666-1674. PubMed ID: 32535629
[TBL] [Abstract][Full Text] [Related]
11. Health Care-Related Economic Burden of Polycystic Ovary Syndrome in the United States: Pregnancy-Related and Long-Term Health Consequences.
Riestenberg C; Jagasia A; Markovic D; Buyalos RP; Azziz R
J Clin Endocrinol Metab; 2022 Jan; 107(2):575-585. PubMed ID: 34546364
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
[TBL] [Abstract][Full Text] [Related]
13. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study.
Ng NYH; Jiang G; Cheung LP; Zhang Y; Tam CHT; Luk AOY; Quan J; Lau ESH; Yau TTL; Chan MHM; Ho CS; Lim CKP; Ozaki R; Huang J; Liu KH; Tam WH; Sahota DS; Chu WCW; Goggins W; Woo J; Li TC; Chow CC; Chan JCN; Ma RCW
PLoS Med; 2019 Oct; 16(10):e1002953. PubMed ID: 31652273
[TBL] [Abstract][Full Text] [Related]
14. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
Fertil Steril; 2018 Aug; 110(3):364-379. PubMed ID: 30033227
[TBL] [Abstract][Full Text] [Related]
15. Association between body mass index, weight loss and the chance of pregnancy in women with polycystic ovary syndrome and overweight or obesity: a retrospective cohort study in the UK.
Haase CL; Varbo A; Laursen PN; Schnecke V; Balen AH
Hum Reprod; 2023 Mar; 38(3):471-481. PubMed ID: 36637246
[TBL] [Abstract][Full Text] [Related]
16. Association between depression risk and polycystic ovarian syndrome in young women: a retrospective nationwide population-based cohort study (1998-2013).
Harnod T; Chen W; Wang JH; Lin SZ; Ding DC
Hum Reprod; 2019 Sep; 34(9):1830-1837. PubMed ID: 31407777
[TBL] [Abstract][Full Text] [Related]
17. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
18. Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study.
Celik C; Tasdemir N; Abali R; Bastu E; Yilmaz M
Fertil Steril; 2014 Apr; 101(4):1123-8.e1. PubMed ID: 24502891
[TBL] [Abstract][Full Text] [Related]
19. The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome.
Moran LJ; Ranasinha S; Zoungas S; McNaughton SA; Brown WJ; Teede HJ
Hum Reprod; 2013 Aug; 28(8):2276-83. PubMed ID: 23771201
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and comorbidities of polycystic ovary syndrome in an indigent population.
Sirmans SM; Parish RC; Blake S; Wang X
J Investig Med; 2014 Aug; 62(6):868-74. PubMed ID: 24844662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
